Baker Brothers sells 322,039 TARA shares; additional broker placements listed (TARA)
Rhea-AI Filing Summary
TARA: A Form 144 filing reports planned or completed dispositions of Common Stock by selling holders. The filing shows a sale of 322,039 shares by Baker Brothers Life Sciences, L.P. on 02/24/2026. It also lists proposed methods and additional sale quantities including 24,186 shares (underwriter) dated 12/08/2025 and 923,293 shares (broker) dated 02/25/2026.
The filing lists intermediaries such as Canaccord Genuity LLC and identifies NASDAQ as the exchange. These entries indicate registered resale activity by institutional holders rather than corporate actions by the issuer.
Positive
- None.
Negative
- None.
Insights
Large institutional resale activity reported, comprised mainly of a 322,039-share completed sale and larger planned broker/underwriter placements.
The excerpt shows a completed disposition of 322,039 shares by Baker Brothers Life Sciences, L.P. on 02/24/2026, plus listed planned sales of 24,186 shares via an underwriter (12/08/2025) and 923,293 shares via broker methods (02/25/2026).
These entries represent selling‑holder transactions and not an issuer issuance; cash‑flow treatment is not specified in the provided excerpt. Subsequent transaction notices or exchange records will show actual execution and timing.